Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024. Read more about Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024.
Social capital as a catalyst for gender inequality: A scoping review of networking disparities in academic medicine. Read more about Social capital as a catalyst for gender inequality: A scoping review of networking disparities in academic medicine.
Using context-specific evidence to inform resource-stratified cancer guidelines: A call for a new approach. Read more about Using context-specific evidence to inform resource-stratified cancer guidelines: A call for a new approach.
Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake. Read more about Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake.
Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trial. Read more about Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trial.
Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures. Read more about Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures.
Neurodegenerative disease pathways are perturbed in patients with cancer who self-report cognitive changes and anxiety: A pathway impact analysis. Read more about Neurodegenerative disease pathways are perturbed in patients with cancer who self-report cognitive changes and anxiety: A pathway impact analysis.
Plant-based diet associated with better quality of life in prostate cancer survivors. Read more about Plant-based diet associated with better quality of life in prostate cancer survivors.
The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer. Read more about The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer.
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers. Read more about A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers.
